Philips · 4 days ago
Senior Product Manager - Cardiac Ultrasound (Cambridge, MA)
Philips is a health technology company dedicated to improving healthcare access for everyone. The Senior Product Manager for Cardiac Ultrasound will own the strategy and management of ultrasound imaging technology and transducers, focusing on enhancing product quality and market adoption in the Diagnostic & Interventional Cardiology segment.
B2BConsumer ElectronicsElectronicsLightingWellness
Responsibilities
Larger focus on working with manufacturing, R&D, and clinical teams to improve quality and reduce costs (upstream)
Define new products, championing them through the product development cycle, launching to the global markets
Work global markets to gain market adoption with the ultimate goal to build profitable product solutions that transform healthcare in the Diagnostic & Interventional Cardiology segment
Own the product lifecycle from concept phase through development and launch and eventually, end of life
Qualification
Required
5+ years of related product management experience in medical device
Ability to synthesize market and customer feedback and existing and new products into solutions
Comfortable with making tradeoffs, decisively
Expertise delivering complex projects to meet demanding feature, cost, quality and introduction date targets
Bachelor's degree
Must be able to successfully perform the following minimum Physical, Cognitive and Environmental job requirements with or without accommodation for this position
Deep expertise in market segmentation, product strategy, competitive strategy, product development, and product launches
Preferred
Experience as a sonographer
MBA
Benefits
Generous PTO
401k (up to 7% match)
HSA (with company contribution)
Stock purchase plan
Education reimbursement
Company
Philips
Philips is a technology company that operates in various fields, including healthcare, consumer electronics, lighting, and home appliances.
Funding
Current Stage
Public CompanyTotal Funding
$4.23BKey Investors
EXOR N.V.Bill & Melinda Gates FoundationInnovative Health Initiative
2025-03-19Post Ipo Equity
2024-05-23Post Ipo Debt· $756.82M
2023-11-07Grant· $44.6M
Recent News
2026-01-06
2025-12-19
Company data provided by crunchbase